Differential Responses to IFN-α Subtypes in Human T Cells and Dendritic Cells

Journal of Immunology

Volumn 171, Issue 10, 2003, Pages 5255-5263

  Hilkens, Catharien M U ^a   Schlaak, Jörg F ^a,b   Kerr, Ian M ^a  

^a THE FRANCIS CRICK INSTITUTE   (United Kingdom)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA BETA INTERFERON RECEPTOR; ALPHA INTERFERON; ALPHA INTERFERON SUBTYPE; ALPHA1 INTERFERON; ALPHA2 INTERFERON; ALPHA21 INTERFERON; BETA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON RECEPTOR; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; STAT PROTEIN; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; CELL SPECIFICITY; CELL TYPE; CELLULAR IMMUNITY; DENDRITIC CELL; ENZYME ACTIVATION; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFLAMMATION; INTERFERON STIMULATED GENE; NUCLEOTIDE SEQUENCE; PHENOTYPIC VARIATION; PLASTICITY; PRIORITY JOURNAL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL;

EID: 0242663859     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.10.5255     Document Type: Article

References (76)

1. Herberman, R. B. 1997. Effect of α-interferons on immune function. Semin. Oncol 24(Suppl 9):S9.78.
2. De Maeyer, E., and J. De Maeyer-Guignard. 1998. Type I interferons. Int. Rev. Immunol. 17:53.
3. Belardelli, F., and I. Gresser. 1996. The neglected role of type I interferon in the T-cell response: implications for its clinical use. Immunol. Today 17:369.
4. Gutterman, J. U. 1994. Cytokine therapeutics: lessons from interferon-α. Proc. Natl. Acad. Sci. USA 91:1198.
5. Diefenbach, A., H. Schindler, N. Donhauser, E. Lorenz, T. Laskay, J. MacMicking, M. Rollinghoff, I. Gresser, and C. Bogdan. 1998. Type I interferon (IFNα/β) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 8:77.
6. Sing, A., T. Merlin, H. P. Knopf, P. J. Nielsen, H. Loppnow, C. Galanos, and M. A. Freudenberg. 2000. Bacterial induction of β-interferon in mice is a function of the lipopolysaccharide component. Infect. Immun. 68:1600.
7. Farrar, J. D., and K. M. Murphy. 2000. Type I interferons and T helper development. Immunol. Today 21:484.
8. Biron, C. A. 2001. Interferons α and β as immune regulators: a new look. Immunity 14:661.
9. Le Bon. A., G. Schiavoni, G. D'Agostino, I. Gresser, F. Belardelli, and D. F. Tough. 2001. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14:461.
10. Weissmann, C., and H. Weber. 1986. The interferon genes. Prog. Nucleic Acid Res. Mol. Biol. 33:251.
11. Pestka, S. 1997. The human interferon-α species and hybrid proteins. Semin. Oncol. 24(Suppl 9):S9.4.
12. Uze, G., G. Luffalla, and I. Gresser. 1990. Genetic transfer of a functional human interferon-α receptor into mouse cells: cloning and expression of its cDNA. Cell 60:225.
13. Novick, D., B. Cohen, and M. Rubinstein. 1994, The human interferon α/β receptor: characterization and molecular cloning. Cell 77:391.
14. Lutfalla, G., S. J. Holland, E. Cinato, D. Monneron, J. Reboul, N. C. Rogers, J. M. Smith, G. R. Stark, K. Gardiner, K. E. Mogensen, et al. 1995. Mutant U5A cells are complemented by an interferon-αβ receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster. EMBO J. 14:5100.
15. Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227.
16. Cho, S. S., C. M. Bacon, C. Sudarshan, R. C. Rees, D. Finbloom, R. Pine, and J. J. O'Shea. 1996. Activation of STAT4 by IL-12 and IFN-α: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation. J. Immunol. 157:4781.
17. Yu, C. R., J. X. Lin, D. W. Fink, S. Akira, E. T. Bloom. and A. Yamauchi. 1996. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-α. J. Immunol. 157:126.
18. Matikainen, S., T. Sareneva, T. Ronni, A. Lehtonen, P. J. Koskinen, and I. Julkunen. 1999. Interferon-α activates multiple STAT proteins and upregulates proliferation-associated IL-2Rα, c-myc, and pim-1 genes in human T cells. Blood 93:1980.
19. Gupta, S., M. Jiang, and A. B. Pernis. 1999. IFN-α activates Stat6 and leads to the formation of Stat2:Stat6 complexes in B cells. J. Immunol. 163:3834.
20. Yang, C. H., A. Murti, S. R. Pfeffer, J. G. Kim, D. B. Donner, and L. M. Pfeffer. 2001. Interferon α/β promotes cell survival by activating nuclear factor κB through phosphatidylinositol 3-kinase and Akt. J. Biol. Chem. 276:13756.
21. Rani, M. R., L. Hibbert, N. Sizemore, G. R. Stark, and R. M. Ransohoff. 2002. Requirement of phosphoinositide 3-kinase and Akt for interferon-β -mediated induction of the β-R1 (SCYB11) gene. J. Biol. Chem. 277:38456.
22. Goh, K. C., S. J. Haque, and B. R. Williams. 1999. p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons. EMBO J. 18:5601.
23. Uddin, S., B. Majchrzak, J. Woodson, P. Arunkumar, Y. Alsayed, R. Pine, P. R. Young, E. N. Fish, and L. C. Platanias. 1999. Activation of the p38 mitogen-activated protein kinase by type I interferons. J. Biol. Chem. 274:30127.
24. Uddin, S., F. Lekmine, N. Sharma, B. Majchrzak, I. Mayer, P. R. Young, G. M. Bokoch, E. N. Fish, and L. C. Platanias. 2000. The Rac1/p38 mitogen-activated protein kinase pathway is required for interferon α-dependent transcriptional activation but not serine phosphorylation of Stat proteins. J. Biol. Chem. 275:27634.
25. David. M., E. Petricoin III, C. Benjamin, R. Pine, M. J. Weber, and A. C. Larner. 1995. Requirement for MAP kinase (ERK2) activity in interferon α- and interferon β-stimulated gene expression through STAT proteins. Science 269:1721.
26. Hiscott, J., K. Cantell, and C. Weissmann. 1984. Differential expression of human interferon genes. Nucleic Acids Res. 12:3727.
27. MacDonald, N. J., D. Kuhl, D. Maguire, D. Naf, P. Gallant, A. Goswamy, H. Hug, H. Bueler, M. Chaturvedi, J. de la Fuente, et al. 1990. Different pathways mediate virus inducibility of the human IFN-α1 and IFN-β genes. Cell 60:767.
28. Marie, I., J. E. Durbin, and D. E. Levy. 1998. Differential viral induction of distinct interferon-α genes by positive feedback through interferon regulatory factor-7. EMBO J. 17:6660.
29. Lin, R., P. Genin, Y. Mamane, and J. Hiscott. 2000. Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of α/β interferon genes by interferon regulatory factors 3 and 7. Mol. Cell Biol 20:6342.
30. Bames, B. J., P. A. Moore, and P. M. Pitha. 2001. Virus-specific activation of a novel interferon regulatory factor, IRF-5. results in the induction of distinct interferon α genes. J. Biol. Chem. 276:23382.
31. Rehberg, E., B. Kelder, E. G. Hoal, and S. Pestka. 1982. Specific molecular activities of recombinant and hybrid leukocyte interferons. J. Biol. Chem. 257:11497.
32. Bell, D. M., N. J. Roberts, Jr., and C. B. Hall. 1983. Different antiviral spectra of human macrophage interferon activities. Nature 305:319.
33. Fish, E. N., K. Banerjee, and N. Stebbing. 1983. Human leukocyte interferon subtypes have different antiproliferative and antiviral activities on human cells. Biochem. Biophys. Res. Commun. 112:537.
34. Foster, G. R., O. Rodrigues, F. Ghouze, E. Schulte-Frohlinde, D. Testa, M. J. Liao, G. R. Stark, L. Leadbeater, and H. C. Thomas. 1996. Different relative activities of human cell-derived interferon-a subtypes: IFN-α8 has very high antiviral potency. J. Interferon Cytokine Res. 16:1027.
35. Yeow, W. S., C. M. Lawson, and M. W. Beilharz. 1998. Antiviral activities of individual murine IFN-α subtypes in vivo: intramuscular injection of IFN expression constructs reduces cytomegalovirus replication. J. Immunol. 160:2932.
36. Hibbert, L., and G. R. Foster. 1999. Human type 1 interferons differ greatly in their effects on the proliferation of primary B cells. J. Interferon Cytokine Res. 19:309.
37. da Silva, A. J., M. Brickelmaier, G. R. Majeau, A. V. Lukashin, J. Peyman, A. Whitty, and P. S. Hochman. 2002. Comparison of gene expression patterns induced by treatment of human umbilical vein endothelial cells with IFN-α2b vs. IFN-β1a: understanding the functional relationship between distinct type I interferons that act through a common receptor. J. Interferon Cytokine Res. 22:173.
38. Cull, V. S., P. A. Tilbrook, E. J. Bartlett, N. L. Brekalo, and C. M. James. 2003. Type I interferon differential therapy for erythroleukemia: specificity of STAT activation. Blood 101:2727.
39. Yonehara, S., M. Yonehara-Takahashi, A. Ishii, and S. Nagata. 1983. Different binding of human interferon α1 and α2 to common receptors on human and bovine cells: studies with recombination interferons produced in Escherichia coli. J. Biol. Chem. 258:9046.
40. Hu, R., Y. Gan, J. Liu, D. Miller, and K. C. Zoon. 1993. Evidence for multiple binding sites for several components of human lymphoblastoid interferon-α. J. Biol. Chem. 268:12591.
41. Abramovich, C., L. M. Shulman, E. Ratovitski, S. Harroch, M. Tovey, P. Eid, and M. Revel. 1994. Differential tyrosine phosphorylation of the TFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-α and IFN-β. EMBO J. 13:5871.
42. Platanias, L. C., S. Uddin, P. Domanski, and O. R. Colamonici. 1996. Differences in interferon α and β signaling: interferon β selectively induces the interaction of the α and βL subunits of the type I interferon receptor. J. Biol. Chem. 271:23630.
43. Domanski, P., O. W. Nadeau, L. C. Platanias, E. Fish, M. Kellum, P. Pitha, and O. R. Colamonici. 1998. Differential use of the βL subunit of the type I interferon (IFN) receptor determines signaling specificity for IFNα2 and IFNβ. J. Biol. Chem. 273:3144.
44. Lewerenz, M., K. E. Mogensen, and G. Uze. 1998. Shared receptor components but distinct complexes for α and β interferons. J. Mol. Biol. 282:585.
45. Hu, R., J. Bekisz, M. Hayes, S. Audet, J. Beeler, E. Petricoin, and K. Zoon. 1999. Divergence of binding, signaling, and biological responses to recombinant human hybrid IFN. J. Immunol. 163:854.
46. Athie-Morales, V., H. Flotow, K. L. Hilyard, and D. A. Cantrell. 2000. IL-12 selectively regulates STAT4 via phosphatidylinositol 3-kinase and Ras-independent signal transduction pathways. Eur. J. Immunol. 30:1425.
47. Schlaak, J. F., C. M. Hilkens, A. P. Costa-Pereira. B. Strobl, F. Aberger, A. M. Frischauf, and I. M. Kerr. 2002. Cell-type and donor-specific transcriptional responses to interferon-α: use of customized gene arrays. J. Biol. Chem. 277:49428.
48. Muller, M., C. Laxton, J. Briscoe, C. Schindler, T. Improta, J. E. Darnell, Jr., G. R. Stark, and I. M. Kerr. 1993. Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-α and -γ signal transduction pathways. EMBO J. 12:4221.
49. Lallemand, C., P. Lebon, P. Rizza, B. Blanchard, and M. G. Tovey. 1996. Constitutive expression of specific interferon isotypes in peripheral blood leukocytes from normal individuals and in promonocytic U937 cells. J. Leukocyte Biol. 60:137.
50. Pohl, G., U. Hellman, E. Lundgren, and S. Lundberg. 1994. Five dominating subtypes in α interferon from Sendai virus stimulated human leukocytes. J. Interferon Res. 14:S63.
51. Foster, G. R., and N. B. Finter. 1998. Are all type I human interferons equivalent? J. Viral Hepat. 5:143.
52. Streuli, M., A. Hall, W. Boll, W. E. Stewart II. S. Nagata, and C. Weissmann. 1981. Target cell specificity of two species of human interferon-α produced in Escherichia coli and of hybrid molecules derived from them. Proc. Natl. Acad. Sci. USA 78:2848.
53. Zoon, K. C., D. Miller, J. Bekisz, D. zur Nedden, J. C. Enterline, N. Y. Nguyen, and R. Q. Hu. 1992, Purification and characterization of multiple components of human lymphoblastoid interferon-α. J. Biol. Chem. 267:15210.
54. Ohmori, Y., and T. A. Hamilton. 1995. The interferon-stimulated response element and a κB site mediate synergistic induction of murine IP-10 gene transcription by IFN-γ and TNF-α. J. Immunol. 154:5235.
55. Ozawa, K., T. Masujima, K. Ikeda, Y. Kodama, and Y. Nonomura. 1996. Different pathways of inhibitory effects of wortmannin on exocytosis are revealed by video-enhanced light microscope. Biochem. Biophys. Res. Commun. 222:243.
56. Luster, A. D., J. C. Unkeless, and J. V. Ravetch. 1985. γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315:672.
57. Khan, I. A., J. A. MacLean, F. S. Lee, L. Casciotti, E. DeHaan, J. D. Schwartzman, and A. D. Luster. 2000. IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. Immunity 12:483.
58. Dufour, J. H., M. Dziejman, M. T. Liu, J. H. Leung, T. E. Lane, and A. D. Luster. 2002. IFN-γ-inducible protein 10 (IP-10: CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 168:3195.
59. Lande, R., E. Giacomini, T. Grassi, M. E. Remoli, E. Iona, M. Miettinen, I. Julkunen, and E. M. Coccia. 2003. IFN-αβ released by Mycobacterium tuberculosis-infected human dendritic cells induces the expression of CXCL10: selective recruitment of NK and activated T cells. J. Immunol. 170:1174.
60. Gottlieb, A. B., A. D. Luster, D. N. Posnett, and D. M. Carter. 1988. Detection of a γ-interferon-induced protein IP-10 in psoriatic plaques. J. Exp. Med. 168:941.
61. + T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. USA 96:6873.
62. Sorensen, T. L., M. Tani, J. Jensen, V. Pierce, C. Lucchinetti, V. A. Folcik, S. Qin, J. Rottman, F. Sellebjerg, R. M. Strieter, et al. 1999. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 103:807.
63. Patel, D. D., J. P. Zachariah, and L. P. Whichard. 2001. CXCR3 and CCR5 ligands in rheumatoid arthritis synovium. Clin. Immunol. 98:39.
64. Shimada, A., J. Morimoto, K. Kodama, R. Suzuki, Y. Oikawa, O. Funae, A. Kasuga, T. Saruta, and S. Narumi. 2001. Elevated serum IP-10 levels observed in type I diabetes. Diabetes Care 24:510.
65. Liu, M. T., H. S. Keirstead, and T. E. Lane. 2001. Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis. J. Immunol. 167:4091.
66. Salomon, I., N. Netzer, G. Wildbaum, S. Schif-Zuck, G. Maor, and N. Karin. 2002. Targeting the function of IFN-γ-inducible protein 10 suppresses ongoing adjuvant arthritis. J. Immunol. 169:2685.
67. Ronnblom, L. E., G. V. Alm, and K. Oberg. 1991. Autoimmune phenomena in patients with malignant carcinoid tumors during interferon-α treatment. Acta Oncol. 30:537.
68. Bosi, E., R. Minelli, E. Bazzigaluppi, and M. Salvi. 2001. Fulminant autoimmune type 1 diabetes during interferon-α therapy: a case of Th1-mediated disease? Diabet. Med. 18:329.
69. Quesada, J. R., and J. U. Gutterman. 1986. Psoriasis and α-interferon. Lancet 1:1466.
70. Hawkins, M. J., E. C. Borden, J. A. Mertitt, B. S. Edwards, L. A. Ball, E. Grossbard, and K. J. Simon. 1984. Comparison of the biologic effects of two recombinant human interferons a (rA and rD) in humans. J. Clin. Oncol. 2:221.
71. Der, S. D., A. Zhou, B. R. Williams, and R. H. Silverman. 1998. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95:15623.
72. Marcus, P. I., and M. J. Sekellick. 1994. Interferon induction: regulation by both virus and cell. Hokkaido Igaku Zasshi 69:1320.
73. Taniguchi, T., and A. Takaoka. 2001. A weak signal for strong responses: interferon-α/β revisited. Nat. Rev. Mol. Cell Biol. 2:378.
74. Sinigaglia, F., D. D'Ambrosio, P. Panina-Bordignon, and L. Rogge. 1999. Regulation of the IL-12/IL-12R axis: a critical step in T-helper cell differentiation and effector function. Immunol. Rev. 170:65.
75. Frucht, D. M., M. Aringer, J. Galon, C. Danning, M. Brown, S. Fan, M. Centola, C. Y. Wu, N. Yamada, H. El Gabalawy, and J. J. O'Shea. 2000. Stat4 is expressed in activated peripheral blood monocytes, dendritic cells, and macrophages at sites of Th1-mediated inflammation. Immunol. 164:4659.
76. Fukao, T., D. M. Frucht, G. Yap, M. Gadina, J. J. O'Shea, and S. Koyasu. 2001. Inducible expression of Stat4 in dendritic cells and macrophages and its critical role in innate and adaptive immune responses. J. Immunol. 166:4446.